Literature DB >> 11950855

Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma.

F Lesueur1, M Corbex, J D McKay, J Lima, P Soares, P Griseri, J Burgess, I Ceccherini, S Landolfi, M Papotti, A Amorim, D E Goldgar, G Romeo.   

Abstract

BACKGROUND: Papillary thyroid carcinoma (PTC), which may be sporadic (95%) or familial (5%), has a prevalence adjusted for age in the general population of 1:100 000. Somatic rearrangements of the RET proto-oncogene are present in up to 66% of sporadic tumours, while they are rarely found in familial cases.
PURPOSE: In order to determine if some variants of this gene, or a combination of them, might predispose to PTC, we looked for an association of RET haplotype(s) in PTC cases and in controls from four countries matched for sex, age, and population.
METHODS: Four single nucleotide polymorphisms (SNPs) across the RET coding sequence were typed and haplotype frequencies were estimated. Genotype and haplotype distributions were compared among these cases and controls.
RESULTS: Ten haplotypes were observed, the seven most frequent of which have been previously described in sporadic Hirschsprung patients and controls. The single locus analyses suggested association of exon 2 and exon 13 SNPs with sporadic PTC. The haplotype analysis showed over-representation of one haplotype in French and Italian sporadic PTC, whereas a different haplotype was significantly under-represented in French familial PTC.
CONCLUSIONS: Our data suggest that some variants of RET and some specific haplotypes may act as low penetrance alleles in the predisposition to PTC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950855      PMCID: PMC1735081          DOI: 10.1136/jmg.39.4.260

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  43 in total

1.  Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression.

Authors:  S Borrego; M E Sáez; A Ruiz; O Gimm; M López-Alonso; G Antiñolo; C Eng
Journal:  J Med Genet       Date:  1999-10       Impact factor: 6.318

2.  RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease.

Authors:  S Borrego; A Ruiz; M E Saez; O Gimm; X Gao; M López-Alonso; A Hernández; F A Wright; G Antiñolo; C Eng
Journal:  J Med Genet       Date:  2000-08       Impact factor: 6.318

3.  Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21.

Authors:  J D McKay; F Lesueur; L Jonard; A Pastore; J Williamson; L Hoffman; J Burgess; A Duffield; M Papotti; M Stark; H Sobol; B Maes; A Murat; H Kääriäinen; M Bertholon-Grégoire; M Zini; M A Rossing; M E Toubert; F Bonichon; M Cavarec; A M Bernard; A Boneu; F Leprat; O Haas; C Lasset; M Schlumberger; F Canzian; D E Goldgar; G Romeo
Journal:  Am J Hum Genet       Date:  2001-07-02       Impact factor: 11.025

4.  Genotype transposer: automated genotype manipulation for linkage disequilibrium analysis.

Authors:  D G Cox; F Canzian
Journal:  Bioinformatics       Date:  2001-08       Impact factor: 6.937

5.  RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH.

Authors:  R Cinti; L Yin; K Ilc; N Berger; F Basolo; S Cuccato; R Giannini; G Torre; P Miccoli; P Amati; G Romeo; R Corvi
Journal:  Cytogenet Cell Genet       Date:  2000

6.  RET rearrangements in familial papillary thyroid carcinomas.

Authors:  R Corvi; F Lesueur; M Martinez-Alfaro; M Zini; M Decaussin; A Murat; G Romeo
Journal:  Cancer Lett       Date:  2001-09-20       Impact factor: 8.679

Review 7.  Familial thyroid cancer.

Authors:  O Alsanea; O H Clark
Journal:  Curr Opin Oncol       Date:  2001-01       Impact factor: 3.645

8.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

9.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

10.  A single-nucleotide polymorphic variant of the RET proto-oncogene is underrepresented in sporadic Hirschsprung disease.

Authors:  P Griseri; M Sancandi; G Patrone; R Bocciardi; R Hofstra; R Ravazzolo; M Devoto; G Romeo; I Ceccherini
Journal:  Eur J Hum Genet       Date:  2000-09       Impact factor: 4.246

View more
  13 in total

1.  Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer.

Authors:  J D McKay; D Thompson; F Lesueur; K Stankov; A Pastore; C Watfah; S Strolz; G Riccabona; R Moncayo; G Romeo; D E Goldgar
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

2.  Case report: a p.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma.

Authors:  X-P Qi; R-B Ying; J-M Ma; W-T Liu; Z-F Du; J Fei; C-P Yang; Q-Z Song; H-Y Jin; Z-G Chen; J-S Han; J-Q Wang; X-L Chen; Y Zhao; J-J Lu; X-N Zhang
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

3.  Quantitative assessment of the association between L769L and S836S polymorphisms at RET gene and medullary thyroid carcinoma risk.

Authors:  Yuanqi Zhang; Sanming Wang; Xiaodong Chen; Shengchao Huang; Jianwen Li
Journal:  Tumour Biol       Date:  2014-04-04

4.  Mutation of RET gene in Chinese patients with Hirschsprung's disease.

Authors:  Ji-Cheng Li; Shi-Ping Ding; Ying Song; Min-Ju Li
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

5.  Polymerase chain reaction-single strand conformational polymorphism analysis of rearranged during transfection proto-oncogene in Chinese familial Hirschsprung's disease.

Authors:  Tao Guan; Ji-Cheng Li; Min-Ju Li; Jin-Fa Tou
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

6.  Characterization of V804M-mutated RET proto-oncogene associated with familial medullary thyroid cancer, report of the largest Turkish family.

Authors:  M N Basaran; M M Tuna; E Karakılıç; B A Doğan; N N İmga; D Berker; S Güler
Journal:  J Endocrinol Invest       Date:  2014-12-12       Impact factor: 4.256

7.  Absence of allelic imbalance involving EMSY, CAPN5, and PAK1 genes in papillary thyroid carcinoma.

Authors:  M Hidalgo; M E Saez; F J Martinez-Tello; F J Moron; E Ferrero-Herrero; M Labalde-Martinez; D Rigopoulou; C Ballestin-Carcavilla; A Ruiz; J L Royo; R Ramirez-Lorca
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

8.  Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan.

Authors:  Alice J Sigurdson; Charles E Land; Parveen Bhatti; Marbin Pineda; Alina Brenner; Zhanat Carr; Boris I Gusev; Zhaxibay Zhumadilov; Steven L Simon; Andre Bouville; Joni L Rutter; Elaine Ron; Jeffery P Struewing
Journal:  Radiat Res       Date:  2009-01       Impact factor: 2.841

Review 9.  Hirschsprung's disease: clinical dysmorphology, genes, micro-RNAs, and future perspectives.

Authors:  Consolato Maria Sergi; Oana Caluseriu; Hunter McColl; David D Eisenstat
Journal:  Pediatr Res       Date:  2016-09-28       Impact factor: 3.756

10.  RET polymorphisms and sporadic medullary thyroid carcinoma in a Portuguese population.

Authors:  Patrícia Costa; Rita Domingues; Luís G Sobrinho; Maria João Bugalho
Journal:  Endocrine       Date:  2005-08       Impact factor: 3.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.